Trinity Biotech plc logo
Trinity Biotech plc TRIB
$ 0.8 4.9%

Annual report 2023
added 12-21-2024

report update icon

Trinity Biotech plc Income Statement 2011-2024 | TRIB

Annual Income Statement Trinity Biotech plc

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- - 120 M 79.6 M 86.1 M 191 M 441 M 604 M 1.16 B 1.74 B 2.39 B 1.38 B 874 M

Shares

- - 83.6 M 20.9 M 83.6 M 83.6 M 86.5 M 91.9 M 110 M 94.9 M 93.7 M 89.8 M 88.9 M

Historical Prices

1.65 0.74 1.43 3.81 1.03 2.29 5.1 6.92 11.8 17.3 24.6 13.9 9.71

Net Income

- - 929 K -6.39 M -28.9 M -22.1 M -40.3 M -101 M 21.8 M 17.2 M 9.6 M 17.3 M 15.6 M

Revenue

56.8 M 62.5 M 81.1 M 102 M 90.4 M 97 M 99.1 M 99.6 M 100 M 105 M 91.2 M 82.5 M 77.9 M

Cost of Revenue

- - 54.9 M 53.4 M 52.3 M 55.6 M 57.2 M 56.1 M 53.7 M - - - -

Gross Profit

19.4 M 17.3 M 33.5 M 48.6 M 38.1 M 41.4 M 41.9 M 43.5 M 46.5 M 49.4 M 45.2 M 42.3 M 40.1 M

Operating Income

- - 6.62 M 82 K -24.1 M -20.2 M -37.7 M -39.8 M 13.5 M - - - -

Interest Expense

- - - 6.75 M 6.58 M 5.08 M 5.4 M 5.44 M 4.05 M - - - -

EBITDA

- - 6.62 M 82 K -24.1 M -20.2 M -37.7 M -33.7 M 19.1 M 19.9 M 12.6 M 20 M 18.4 M

Operating Expenses

- - - 28.3 M 37.9 M 34.7 M 37.8 M 35.3 M 33 M 32.6 M 36.5 M 25.3 M 25.3 M

General and Administrative Expenses

- - 24.7 M 25.1 M 30.3 M 26.7 M 32.2 M 30.4 M 28.2 M 30.1 M 33.1 M 22.4 M 22 M

All numbers in USD currency

Quarterly Income Statement Trinity Biotech plc

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - - - - - - - - - - - - - 26.2 M - - - 27.1 M - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - - - - - - - - - - - - - 594 K - - - 902 K - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - 25 M - - - 25.4 M - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - 14.2 M - - - 14.6 M - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - 10.8 M - - - 10.8 M - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - 1.73 M - - - 1.83 M - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - - - - - - - - - - - 1.73 M - - - 1.83 M - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - - - - - - - - - - - - - 7.36 M - - - 7.56 M - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency